🕒 Wednesday 17 December 2025 Wed, 17 Dec 2025

Telix Pharmaceuticals confirms completion of Part 1 enrolment in its ProstACT Phase 3 trial for prostate cancer, with safety data supporting progression to Part 2 and regulatory approvals secured across multiple countries.

FlexiRoam has launched Travel AI, the world’s first AI-powered eSIM agent integrated into WhatsApp, aiming to revolutionize how travellers and enterprises manage connectivity.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

GenusPlus Group confirms the green light to commence a $140 million sub-transmission line construction for Ausgrid’s Hunter-Central Coast Renewable Energy Zone, starting February 2026.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.

Hawsons Iron Ltd has declared a JORC-compliant Probable Ore Reserve of 2.3 billion tonnes and completed a positive Pre-Feasibility Study supporting a 26-year, 12Mtpa magnetite concentrate project in New South Wales.

Elders Limited has updated its dividend details for the half-year ending September 2025, declaring a fully franked 18 cents per share dividend payable in December, alongside a discounted dividend reinvestment plan.

Torque Metals has raised $16.2 million through a $15 million placement and early option exercises, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

NTAW Holdings has secured an extension of its financial covenant waiver with Commonwealth Bank of Australia until March 2026, while continuing to reduce its borrowing facility.

RocketDNA has secured approximately A$1 million in new orders from major mining clients, expanding its autonomous drone deployments and software services across Australia and Africa.

Dexus reports a modest $83 million uplift in portfolio valuation driven by rental growth, alongside an estimated 19.3 cents per security distribution for H2 2025.

Middle Island Resources has appointed Peter Spiers as CEO, aiming to accelerate exploration and development of its Serbian projects with his extensive industry expertise.

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Credit Corp Group has submitted a non-binding indicative proposal to acquire Humm Group, marking a potential consolidation in the consumer finance sector. The proposal remains conditional as due diligence information is yet to be provided.

Truscott Mining Corporation has initiated a $1.44 million capital raise through a share placement accompanied by unlisted options, aiming to bolster its exploration and development efforts.

Opthea Limited has announced a strategic pivot to develop OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women, aiming for ASX reinstatement in 2026. The company leverages strong intellectual property and cash reserves to pursue orphan drug designation and clinical development.

Humm Group has received a shareholder notice to remove key directors alongside a non-binding acquisition proposal from Credit Corp, signaling potential major changes ahead.

Neurotech International has locked in $4 million through a share placement to advance its promising paediatric neurological drug, NTI164. The raise, supported by both new and existing investors including company directors, aims to fund critical clinical and regulatory milestones.

Cassius Mining Limited has raised $1.16 million through a share placement to fund its Soalara project in Madagascar and support ongoing litigation in Ghana.

Variscan Mines has secured government approval for its Preliminary Mining Plan, enabling critical pre-works and trial mining at the San Jose Mine in Spain. This milestone accelerates the company’s strategy to restart production with minimal capital expenditure.

Rapid Critical Metals has announced the discovery of a new parallel silver lode at its Webbs Silver Project in northern New South Wales, following a 2,000-metre diamond drilling program. Early results reveal strong silver mineralisation, opening promising avenues for resource expansion.

Anson Resources has secured regulatory approval for a revised drilling approach at its Mt Fuel-Skyline Geyser Well in Utah, overcoming unexpected blockages to advance lithium exploration.